EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Efficient expansion and CRISPR-Cas9-mediated gene correction of patient-derived hepatocytes for treatment of inherited liver diseases

Kun Zhang, Ping Wan, Liren Wang, Zhen Wang, Fangzhi Tan, Jie Li, Xiaolong Ma, Jin Cen, Xiang Yuan, Yang Liu, Zhen Sun, Xi Cheng und 7 weitere

Cell Stem Cell · 2024

DOI: 10.1016/j.stem.2024.04.022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Stem Cell, 2024. Verfasst von Kun Zhang und 18 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Multi-Cell Systems, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese A…. Hauptthemen laut MEDLINE: Hepatocytes, CRISPR-Cas Systems, Liver Diseases, Gene Editing. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HepatocytesCRISPR-Cas SystemsLiver DiseasesGene EditingGenetic TherapyHumansAnimalsMiceTyrosinemiasCell ProliferationHydrolases

Stichwörter der Autor:innen

AAV screenProliHHsautologous cell therapygene correctiongene editinggene knockinhepatocyte culturehepatocyte transplantationinherited liver diseases

Substanzen

fumarylacetoacetaseHydrolases

Autor:innen und Institutionen

  • Key Laboratory of Multi-Cell Systems, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai 200031, China. Electronic address: kun.zh…
  • Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200001, China.
  • Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai 2…
  • Key Laboratory of Multi-Cell Systems, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai 200031, China.
  • iHuman Institute, ShanghaiTech University, Shanghai 201210, China.
  • The MOE Key Laboratory of Cell Proliferation and Differentiation, School of Life Sciences, Genome Editing Research Center, Peking University, Beijing 100871, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhang, K., Wan, P., Wang, L., Wang, Z., Tan, F., Li, J., Ma, X., Cen, J., Yuan, X., Liu, Y., Sun, Z., Cheng, X., Liu, Y., Liu, X., Hu, J., Zhong, G., Li, D., Xia, Q., & Hui, L. (2024). Efficient expansion and CRISPR-Cas9-mediated gene correction of patient-derived hepatocytes for treatment of inherited liver diseases. Cell Stem Cell. https://doi.org/10.1016/j.stem.2024.04.022

Vancouver

Zhang K, Wan P, Wang L, Wang Z, Tan F, Li J, et al. Efficient expansion and CRISPR-Cas9-mediated gene correction of patient-derived hepatocytes for treatment of inherited liver diseases. Cell Stem Cell. 2024. doi:10.1016/j.stem.2024.04.022

BibTeX
@article{Zhang2024,
  author = {Zhang, Kun and Wan, Ping and Wang, Liren and Wang, Zhen and Tan, Fangzhi and Li, Jie and Ma, Xiaolong and Cen, Jin and Yuan, Xiang and Liu, Yang and Sun, Zhen and Cheng, Xi and Liu, Yuanhua and Liu, Xuhao and Hu, Jiazhi and Zhong, Guisheng and Li, Dali and Xia, Qiang and Hui, Lijian},
  title = {Efficient expansion and CRISPR-Cas9-mediated gene correction of patient-derived hepatocytes for treatment of inherited liver diseases},
  journal = {Cell Stem Cell},
  year = {2024},
  doi = {10.1016/j.stem.2024.04.022}
}
Kostenlos starten →